IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 335 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $966 | -99.9% | 25,580 | +39.7% | 0.10% | +26.0% |
| Q2 2022 | $678,000 | +100.0% | 18,310 | +64.5% | 0.08% | +102.6% |
| Q4 2021 | $339,000 | -12.2% | 11,134 | -3.2% | 0.04% | -17.4% |
| Q3 2021 | $386,000 | +56.9% | 11,500 | +122.3% | 0.05% | +15.0% |
| Q3 2020 | $246,000 | -50.1% | 5,174 | -53.8% | 0.04% | -45.2% |
| Q1 2018 | $493,000 | +77.3% | 11,190 | +102.0% | 0.07% | +49.0% |
| Q4 2017 | $278,000 | -2.5% | 5,540 | -1.1% | 0.05% | +6.5% |
| Q3 2017 | $285,000 | -25.2% | 5,600 | -25.3% | 0.05% | -36.1% |
| Q2 2017 | $381,000 | – | 7,500 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |